Searchable abstracts of presentations at key conferences in endocrinology

ea0081p496 | Thyroid | ECE2022

Outcomes of low-risk differentiated thyroid cancer submitted to radioactive iodine ablation - a comparative analysis in a single tertiary centre

Ivo Catarina , Amaral Sara , Raposo Nuno , Maciel Joana , Simoes Pereira Joana , Vilar Helena , Leite Valeriano

Introduction: The update of 2015 American Thyroid Association (ATA) guidelines recommend that radioactive iodine (RAI) ablation therapy should be used in line with patients’ risk stratification. However, there is no consensus on benefits of post-operative RAI ablation in patients with low risk differentiated thyroid cancer (DTC). The aim of this study is to compare the outcomes of patients with low risk DCT submitted to RAI ablation with those who were not.<p class="a...

ea0081p497 | Thyroid | ECE2022

Impact of 2015 ATA guidelines in 131I prescription in low-risk DTC

Amaral Sara , Ivo Catarina , Cordeiro Raposo Nuno , Maciel Joana , Simoes-Pereira Joana , Vilar Helena , Leite Valeriano

Background: To minimize potential harm from overtreatment of low-risk thyroid cancers, the 2015 American Thyroid Association (ATA) Guidelines recommend that radioactive iodine (RAI) ablation should not be routinely used in low-risk differentiated thyroid carcinoma (DTC). The present study aims to evaluate trends in RAI therapy in a tertiary center after the update of these Guidelines.Methods: Data from patients followed in a tertiary center with low-risk...

ea0041ep172 | Calcium and Vitamin D metabolism | ECE2016

Roux-en-Y Gastric Bypass reversal due to recalcitrant hypocalcaemia after total thyroidectomy

Silva Joao , Ivo Catarina , Simoes Helder , Lopes Luis , Passos Dolores , Marcelino Mafalda , de Castro Joao Jacome

Introduction: Hypocalcaemia is a potential post-thyroidectomy complication. Patients with previous Roux-en-Y Gastric Bypass (RYGBP) are at increased risk of symptomatic hypocalcaemia refractory to treatment. This complication is rare and there is not consensus on how to act.Clinic case: Female with 34 years old, with a history of Obesity (BMI 45.7 kg/m2), submitted to RYGBP in 2013, with a total loss of 47 kg (current BMI 27.3 kg/m2...

ea0041ep385 | Clinical case reports - Thyroid/Others | ECE2016

Thyroid, the Heart and Amiodarone

Ivo Catarina , Silva Joao , Simoes Helder , Monge Jose , Lopes Carlos , Marcelino Mafalda , Castro Joao Jacome de

Introduction: The hyperthyroidism is a risk factor for tachyarrhythmia and dilated cardiomyopathy. Amiodarone is an effective antiarrhythmic medication, however if coexisting thyroid pathology complicates the treatment of thyroid dysfunction. It presents a case of Graves’ disease (GD) of long evolution, which illustrates the complexity of these associations. Clinical case: man, 44 years old, smoker, history of acute myocardial infarction and GD diagnosed at age 28. Has ma...

ea0041ep448 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Clinical inertia in type 2 diabetes mellitus without insulin treatment

Silva Joao , Ivo Catarina , Lopes Luis , Passos Dolores , Simoes Helder , Marcelino Mafalda , Jacome de Castro Joao

Introduction: Clinical inertia applied to type2 Diabetes Mellitus (T2DM) treatment, is defined as a lack of treatment’s intensification of patients who are not in HbA1c target. Clinical inertia leads to a postponement of new therapeutic introduction, with all complications associated with a poor metabolic control. In Portugal there are only studies that show good or poor metabolic control but do not mention clinician’s attitude towards these values. Recently publishe...

ea0041ep556 | Diabetes therapy | ECE2016

Effects of SGLT2 inhibitors in the treatment of a population with type 2 diabetes mellitus

Silva Joao , Ivo Catarina , Passos Dolores , Simoes Helder , Lopes Luis , Marcelino Mafalda , de Castro Joao Jacome

Introduction: The SGLT-2 inhibitors (InibSGLT2) are the newest class of non-insulin antidiabetic drugs (ANI) for type 2 diabetes mellitus (T2DM) treatment. Currently is only available in Portugal, dapagliflozin. This pharmacological class have shown benefits in metabolic control (reduction of 0.5–0.8% HbA1c) and in weight loss (1–3 kg).Objective: Evaluate the impact of InibSGLT2 in patients with T2DM followed in a Diabetes department.<p cla...

ea0037gp.25.04 | Thyroid – nodule | ECE2015

Evaluation of benign thyroid nodules in a 10-year follow-up

Silva Joao , Ivo Catarina , Marcelino Mafalda , Simoes Helder , Lopes Luis , Passos Dolores , de Castro Joao Jacome

Introduction: American Thyroid Association recommends that benign thyroid nodules should be revaluated 6–18 months after initial FNA and in case of stability the follow-up should be 3–5 years. However there isn’t any consensus about the periodicity of the follow-up.Aim: To evaluate the nodules in terms of function, size and malignancy in a 10-year follow-up.Methods: Retrospective study of 347 patients (543 benign thy...

ea0037ep299 | Calcium and Vitamin D metabolism | ECE2015

Parathyroid tissue in ectopic thyroid tissue

Silva Joao , Ivo Catarina , Marcelino Mafalda , Passos Dolores , Simoes Helder , Lopes Luis , de Castro Joao Jacome

Introduction: Postmortem studies have shown that a fifth parathyroid gland may be present in about 5% of patients with hyperparathyroidism. 1% of parathyroid glands are located in thyroid tissue. There’s a prevalence of 7–10% of thyroid ectopic tissue.Case report: A 53-year-old male, submitted to bilateral nephrectomy due to a Grawitz tumour at the age of 25. Under haemodialysis since then (with a rejected renal transplant in the past), he was ...

ea0037ep488 | Diabetes (complications &amp; therapy) | ECE2015

Hypoglycaemia due to drug interaction with clarithromycin

Silva Joao , Ivo Catarina , Marcelino Mafalda , Lopes Luis , Passos Dolores , Simoes Helder , de Castro Joao Jacome

Introduction: Interaction between diabetes mellitus (DM) and an infection usually results in hyperglycaemia. However, there is data describing hypoglycaemia events related with the association between certain antibiotics and oral anti-diabetic drugs or insulin.Case report: Male, 73 years old, with history of hypertension, obesity and dyslipidaemia. DM type 2 was diagnosed 13 years ago with any macro or microvascular complications so far. Currently he&#14...

ea0081p281 | Adrenal and Cardiovascular Endocrinology | ECE2022

Management of pheochromocytoma and hyperaldosteronism coexistence

Verissimo David , Ivo Catarina , Duarte Vitoria , Martins Ana Claudia , Silva Joao , Lopes Luis , Passos Dolores , Castro J Jacome , Marcelino Mafalda

Introduction: Primary hyperaldosteronism (PHA) and pheochromocytoma are endocrine causes of secondary arterial hypertension. The association of hyperaldosteronism and pheochromocytoma is rare and the involved mechanisms are poorly understood. Either there is coexistence of the two diseases (pheochromocytoma with PHA) or the pheochromocytoma stimulates the production of aldosterone.Case Report: Male, 54 years old, referred to our department for type 2 dia...